NBIX Neurocrine Biosciences Inc.


554,049 Shares Traded
972,964 Average Volume (last 30 days)

as of February 23, 2018 EST IEX Real-Time Price

Short Pain Metrics

Approximate Amount of Money Shorts Have Made on the Day: $604.11 million
If Intiated on the First, Shorts Have Realized a Year to Date Return of:-7.72%
If Intiated One Month Ago, Shorts Have Realized a Return of:-0.27%
If Initiated Five Days ago, Shorts Have Realized a Return of:0.18%
Peer Potential Short Squeezes Near Real Time Screener
*Please note the actual returns of shorts could be different as they started from different points

Daily Indicators

Daily Short Pain Indicator [i] - Always Use Fundamentals on EverythingNeutral
200 Day Moving Average Indicator Bearish
50 Day Moving Average Indicator Bearish
52 Week High/Low Indicator Neutral

Short Stats

Short Percent to Float 8.15%
Short Interest7.12 million
Float87.33 million
Short Ratio6.36
Market Cap$7.63 billion
Market Maker ActivityDaily Short Volume


3 Things In Biotech You Should Learn Today: February 22, 2018 (SeekingAlpha)
Biotech Forum Daily Digest For Feb. 22 (SeekingAlpha)
Another Phase III Win For Neurocrine Biosciences (SeekingAlpha)
Time To Take Profits On Neurocrine Biosciences, And Then Wait For The Rekindling (SeekingAlpha)
Neurocrine Biosciences: Q4 Update (SeekingAlpha)
AbbVie's elagolix successful in late-stage uterine fibroid study (SeekingAlpha)
AbbVie Announces Positive Topline Results from Phase 3 Study Evaluating Investigational Elagolix in Women with Uterine Fibroids (PR Newswire)
Biotechs: Still Well Placed For More Gains (SeekingAlpha)
Neurocrine Biosciences Shows Again That Sometimes The Tortoise Wins (SeekingAlpha)
Here are 5 top stock picks from Wall Street analysts for a choppy market (CNBC)

Earnings Stats

PE Ratio -52.09
Dividend Yield 0%
Peer EarningsEarnings Calendar


200 Day Moving Average $62.03
50 Day Moving Average $79.8
52 Week High $91.82
52 Week Low $39.21

Data provided for free by IEX. Questions? Read the FAQ